Archon Biosciences
Latest round
- Series A
Last raised
- May 2023
Total raised
- $20M
Investors
- 7
About Archon Biosciences
Based in Washington, US, Archon Biosciences, Inc. specializes in developing advanced protein therapeutics called antibody cages (AbCs), targeting complex disease pathways to improve treatment outcomes in areas like oncology and autoimmune disorders. In October 2024, Archon Biosciences, Inc. The company provides a wide range of biotechnology products, such as antibody cages (AbCs), which combine AI-driven design and structural engineering to optimize antibody distribution, binding affinity, and target engagement. These therapeutics are engineered for applications that require precise control over size, shape, and function to address diseases that traditional therapies cannot reach. Additionally, the firm also provides solutions in generative protein design and Fc-based biologics for advanced drug development. Archon Biosciences targets markets primarily in North America and Europe. Archon Biosciences operates on a model that emphasizes partnerships and collaborations with pharmaceutical companies and research institutions. The company’s flagship antibody cage platform, recognized for its approach to biologics, serves as the cornerstone of these collaborations. Transactions are structured around B2B relationships, wherein clients may engage in research and development partnerships to leverage Archon's technological capabilities for their therapeutic pipelines. In October 2024, Archon Biosciences, Inc. The company plans to introduce new products targeting these therapeutic areas and aims to expand into additional markets globally, particularly focusing on regions in Asia and further into Europe by 2025.
Who invested in Archon Biosciences
7 investors across 1 round
See all investors in Archon Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 30, 2023
Amount
$20M
Investors
Questions about Archon Biosciences
Who invested in Archon Biosciences?
Archon Biosciences has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Archon Biosciences raised?
Archon Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Archon Biosciences last raise money?
Archon Biosciences's most recent round on record is a Series A, in May 2023.
What does Archon Biosciences do?
Based in Washington, US, Archon Biosciences, Inc.
Where is Archon Biosciences headquartered?
Archon Biosciences is headquartered in Seattle, US.
Which VCs invest in companies like Archon Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Archon Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Archon Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.